Search clinical trials for: YYC405-T placebo

Total 56616 results

Yooyoung Pharmaceutical Co., Ltd.

Completed

Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A

Dyslipidemias

Korea, Republic of
Yooyoung Pharmaceutical Co., Ltd.

Active, not recruiting

Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients

Type 2 Diabetes

Korea, Republic of
Yooyoung Pharmaceutical Co., Ltd.

Active, not recruiting

Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506

Dyslipidemias

Korea, Republic of
Yooyoung Pharmaceutical Co., Ltd.

Recruiting

Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506. (Atorf-YOOrct)

Dyslipidemias

Korea, Republic of
Yooyoung Pharmaceutical Co., Ltd.
CliPSBnC

Recruiting

Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee

Osteoarthritis, Knee

Korea, Republic of
FUJIFILM Toyama Chemical Co., Ltd.
Alzheimer's Disease Cooperative Study (ADCS)

Completed

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)

Alzheimer's Disease

United States
FUJIFILM Toyama Chemical Co., Ltd.

Completed

Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

Mild Cognitive Impairment

Netherlands, United Kingdom, Ireland, Spain, Germany, Czechia, Hungary
Vericel Corporation

Completed

An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) (ixCELLDCM)

Ischemic Dilated Cardiomyopathy (IDCM)

United States, Canada
Vericel Corporation

Completed

Use of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia (RESTORE-CLI)

Peripheral Arterial Disease

United States
National Institute of Mental Health (NIMH)

Completed

Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.

HIV Infections | Cognition Disorders

United States
FUJIFILM Toyama Chemical Co., Ltd.

Completed

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States, Canada
Chenland Nutritionals Inc.
KGK Science Inc.

Completed

The Safety and Efficacy of MoodElite T-4003-1 on Improving Mood in a Healthy Adult Population With Mild to Moderate Depressive Symptoms Not Eligible for Therapeutic Intervention

Mood

Canada
Pfizer

Terminated

Analgesic Efficacy and Safety Study of T-62 in Subjects With Postherpetic Neuralgia

Postherpetic Neuralgia

United States
Arbutus Biopharma Corporation

Terminated

Safety, Tolerability, and Pharmacokinetics of AB-836 in Healthy Subjects and Subjects With Chronic HBV Infection

Chronic Hepatitis

Korea, Republic of, Hong Kong, Thailand, Canada, Australia, Moldova, Republic of, New Zealand, Ukraine
Castle Creek Biosciences, LLC.

Completed

Safety and Efficacy Study of Autologous Fibroblasts in the Treatment of Severe Facial Acne Scarring

Acne Scarring of the Face

United States
Castle Creek Biosciences, LLC.

Completed

Safety and Efficacy Study of Isolagen TherapyTM in the Treatment of Nasolabial Fold Wrinkles

Bilateral Nasolabial Fold Wrinkles

United States
Castle Creek Biosciences, LLC.

Completed

Safety and Efficacy Study of Isolagen Therapy in the Treatment of Nasolabial Fold Wrinkles

Bilateral Nasolabial Fold Wrinkles

United States
Castle Creek Biosciences, LLC.

Terminated

Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars

Restrictive Burn Scars

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Shock Syndrome

Puerto Rico
Arbutus Biopharma Corporation

Recruiting

Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

Chronic Hepatitis b

New Zealand
Anagnostou, Evdokia, M.D.
Unity Health Toronto; Holland Bloorview Kids Rehabilitation Hospital; Ontario...

Unknown

A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome

Rett Syndrome

Canada
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers

Influenza

Finland
cerbomed GmbH
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

Completed

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia (02VNS2009)

Schizophrenia

Germany
Dendreon

Completed

Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer

Hormone-Refractory Prostate Cancer
Dendreon

Completed

Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Prostate Cancer

United States, Canada
Artielle ImmunoTherapeutics

Unknown

Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis

Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting

United States
Biotronik SE & Co. KG

Completed

Eluna Family / Sentus BP Master Study

Heart Failure | Bradycardia

Denmark, Hong Kong, Austria, Germany, Belgium
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand

Dengue

Thailand
Dendreon

Completed

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer

United States
Atara Biotherapeutics

Terminated

Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis (EMBOLD)

Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis

United States, Australia, Canada
Opexa Therapeutics, Inc.

Completed

Autologous T Cell Vaccine (TCV) for Multiple Sclerosis (TERMS)

Relapsing-Remitting Multiple Sclerosis

United States
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.

Influenza

United States
University of California, Berkeley
University of Nevada, Reno; World Bank; L'Office National de Nutrition, Madagascar

Recruiting

Integrating Early Stimulation and Play at Scale: "MAHAY Mikolo"

Early Childhood Development

Madagascar
Castle Creek Biosciences, LLC.

Completed

Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia

Dysphonia Resulting From Vocal Fold Scarring | Age-related Dysphonia

United States
Biotronik SE & Co. KG

Completed

Remote Follow-up of Patients Receiving Implantable Cardioverter Defibrillator for Prophylactic Therapy (REFORM)

Ventricular Fibrillation | Ventricular Tachycardia

Germany, Czech Republic
University of South Florida
National Cancer Institute (NCI)

Recruiting

NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors (NOURISH-T+)

Cancer | Obesity, Childhood | Survivorship

United States
Hebei Senlang Biotechnology Inc., Ltd.

Recruiting

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

Lymphoma | Multiple Myeloma | Acute Lymphoblastic Leukemia

China
VTBIO Co. LTD
BHT Lifescience Austrailia Pty Ltd.

Unknown

A Safety and Tolerability Study of GB301

Alzheimer Disease

Australia
Florida State University
East Carolina University

Completed

Multi-ingredient Supplement for Strength and Power

Supplement

United States
University of Sao Paulo

Completed

24-Wk β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males

Sports Nutritional Physiological Phenomena
Xuzhou Medical University

Not yet recruiting

Safety and Efficacy of Treg Cell in the Treatment of GVHD

GVHD
The First Affiliated Hospital of Soochow University

Recruiting

Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma

Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

China
City of Hope Medical Center
National Cancer Institute (NCI); California Institute for Regenerative Medicine...

Recruiting

HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases

Breast Cancer | HER2-positive Breast Cancer | Malignant Neoplasm | Metastatic Malignant Neoplasm in the Brain | Metastatic Malignant Neoplasm in the Leptomeninges

United States
King's College London
Imperial College London; Medical Research Council; Guy's and St Thomas' NHS Foundation... and other collaborators

Unknown

Treg Immunotherapy in Crohn's Disease (TRIBUTE)

Crohn Disease
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years. (FluMist)

Influenza

Belgium, Poland, United Kingdom
Everett Meyer
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

Lymphoma, Non-Hodgkin | Acute Myeloid Leukemia | Acute Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myelodysplastic Syndromes (MDS) | Acute Lymphoblastic Leukemia (ALL) | Myeloid Leukemia, Chronic | Myeloproliferative Syndrome

United States
Sorrento Therapeutics, Inc.

Withdrawn

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)

Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreas Cancer | Peritoneal Carcinomatosis | Peritoneal Metastases | Carcinoembryonic Antigen

United States
The First Affiliated Hospital of Guangdong Pharmaceutical...
Guangzhou Anjie Biomedical Technology Co., Ltd.

Unknown

CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer

Advanced Esophageal Cancer

China
Assiut University

Not yet recruiting

T Regulatory Cells IN LUPUS NEPHRITIS

Lupus Nephritis
Hams Hamed Abdelrahman

Completed

Titanium Prepared Platelet-rich Fibrin in Bone Regeneration in Lateral Window Maxillary Sinus Augmentation

Sinus Lifting

Egypt

Search clinical trials for: YYC405-T placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations